David Gilham is the former Vice President of Research and Development and Chief Scientific Officer at Celyad, a Belgian biopharmaceutical company.
Dr. David Gilham is the former Vice President of Research and Development and Chief Scientific Officer at Celyad, a Belgian biopharmaceutical company. His expertise lies in CAR-T cells, specifically engineering T-cells for cancer therapies and preclinical study development.
Full founder directory · Investor directory · Company funding database · Fundraising library